Both in Biotechnology
enGene Therapeutics vs Voyager Therapeutics
Over the past year ENGN returned −73.7% and VYGR returned −55.0%; their daily moves had a correlation of 0.16.
ENGN −73.7% VYGR −55.0%Growth of $1, one year, split-adjusted
| Metric | ENGN | VYGR |
|---|---|---|
| Price | $1.72 | $1.87 |
| Market cap | $115.3M | $115.2M |
| Today | +6.17% | +2.19% |
| 1 month | −4.4% | −24.0% |
| 6 months | −80.6% | −55.2% |
| Year to date | −81.0% | −52.4% |
| 1 year | −75.1% | −59.3% |
| Revenue growth (YoY) | — | −39.1% |
| Gross margin | — | 100.0% |
| Net margin | — | −773.2% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.3× |
| Net cash | $241.0M | $116.3M |
| Dividend yield | — | — |
| Volatility (60d) | 58.2% | 61.1% |
| Short % of float | 3.4% | 7.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).